NCT06581432 2026-04-17Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 AlterationsBoehringer IngelheimPhase 2 Recruiting430 enrolled
NCT04529122 2026-04-06A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing TestHoffmann-La RocheRecruiting15,000 enrolled
NCT07160725 2026-03-24A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid TumorsBristol-Myers SquibbPhase 1/2 Recruiting315 enrolled